News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32181)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Biotech Bay
Anthera Pharmaceuticals Announces Pricing of $15M Private Placement Offering
The PIPE is expected to have two closings.
October 24, 2017
·
4 min read
Business
Alphatec Announces Preliminary Third Quarter 2017 Financial Results and Corporate Updates
The Company also announced several corporate updates.
October 24, 2017
·
8 min read
Drug Development
Cellectar Biosciences Introduces Multiple Dose Regimen in Fifth Cohort of Phase 1 Trial of CLR 131 in Multiple Myeloma
In September, the trial’s Data Monitoring Committee (DMC) determined that the fourth cohort single dose of 31.25 mCi/m2 was safe and tolerated.
October 24, 2017
·
6 min read
BioCapital
K2M to Feature First FDA-Cleared 3D-Printed Expandable Interbody System, Industry-Leading 3D-Printed Portfolio, & Balance ACS Platform at NASS 2017
Favorable data on K2M’s cervical spinal solutions to be presented during scientific sessions.
October 24, 2017
·
11 min read
Policy
Myriad Submits BRACAnalysis CDx Application for Regulatory Approval in Japan for HER2- Metastatic Breast Cancer
Myriad estimates there are greater than 10,000 cases of HER2- metastatic breast cancer per year in Japan which would be eligible for testing with BRACAnalysis CDx.
October 24, 2017
·
6 min read
Business
Resverlogix Announces Right of First Refusal Agreement With Hepalink USA
Hepalink paid $8 million (the “Fee”) to Resverlogix in consideration for the right of first refusal granted.
October 24, 2017
·
4 min read
Pharm Country
USPTO Grants Composition of Matter Patent to Achillion for ACH-4471, First-in-Class Small Molecule Complement Alternative Pathway Factor D Inhibitor
This issued patent will be the eighth patent that the USPTO has granted to Achillion this year on its complement factor D portfolio.
October 24, 2017
·
5 min read
Blegian Scientist Erik Jacquemyn to receive UNESCO Kalinga Prize for the Popularization of Science
UNESCO Director-General Irina Bokova will award the UNESCO Kalinga Prize for the Popularization of science to Erik Jacquemy (Belgium) in a ceremony to be held on 7 November during the World Science Forum in Jordan.
October 24, 2017
·
1 min read
Business
Sébastien Desprez Joins Adaptimmune as Vice President of Communications and Investor Relations
Sébastien has more than twenty years of experience in biotech and healthcare communications
October 24, 2017
·
3 min read
BioCapital
Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane
This scientific study was a collaborative effort of scientists from the NJCBM at Rutgers, The State University of New Jersey in the laboratory of Professor Joachim Kohn and Osiris Therapeutics.
October 24, 2017
·
5 min read
Previous
7 of 15
Next